Differential Diagnosis of Tumor-like Brain Lesions
- PMID: 37664132
- PMCID: PMC10468256
- DOI: 10.1212/CPJ.0000000000200182
Differential Diagnosis of Tumor-like Brain Lesions
Abstract
Purpose of review: Tumor-like brain lesions are rare and commonly suggest a neoplastic etiology. Failure to rapidly identify non-neoplastic causes can lead to increased morbidity and mortality. In this review, we describe 10 patients who presented with atypical, non-neoplastic tumor-like brain lesions in which brain biopsy was essential for a correct diagnosis and treatment.
Recent findings: There has been increasing recognition of autoimmune conditions affecting the nervous system, and many of those diseases can cause tumor-like brain lesions. Currently available reports of non-neoplastic tumor-like brain lesions are scarce. Most case series focus on tumefactive demyelinating lesions, and a comprehensive review including other neuroimmunological conditions such as CNS vasculitis, neurosarcoidosis, histiocytic and infectious etiologies is lacking.
Summary: We review the literature on tumor-like brain lesions intending to increase the awareness and differential diagnosis of non-neoplastic brain tumor mimics. We advocate for earlier brain biopsies, which, in our case series, significantly changed diagnosis, management, and outcomes.
© 2023 American Academy of Neurology.
Conflict of interest statement
G.S. Perez reports no disclosures relevant to the manuscript; L. Singer reports no disclosures relevant to the manuscript; T. Cao reports no disclosures relevant to the manuscript; P. Jamshidi reports no disclosures relevant to the manuscript; K. Dixit reports no disclosures relevant to the manuscript; M. Kontzialis reports no disclosures relevant to the manuscript; R. Castellani reports no disclosures relevant to the manuscript; P. Pytel reports no disclosures relevant to the manuscript; N. Anadani reports no disclosures relevant to the manuscript; C. Bevan has participated in an ad board for Genentech; E. Grebenciucova reports no disclosures relevant to the manuscript; R. Balabanov received honoraria from Biogen, Sanofi, Alexion, and Teva Pharmaceutical and research support from the National Multiple Sclerosis Society, National Institute of Health, Nextcure, and Biogen; B. Cohen reports no disclosures relevant to the manuscript. E. Graham received consulting and advisory board fees from Novartis, Atara Biotherapeutics, Tavistock Life Sciences, Horizon Therapeutics, Roche Genentech. She receives research support from F. Hoffman-La Roche Ltd. She received compensation for question writing from ACP MKSAP. Full disclosure form information provided by the authors is available with the full text of this article at Neurology.org/cp.
Figures





Similar articles
-
Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum.Qatar Med J. 2022 Jul 7;2022(3):29. doi: 10.5339/qmj.2022.29. eCollection 2022. Qatar Med J. 2022. PMID: 35864917 Free PMC article.
-
Tumefactive demyelinating lesions: A comprehensive review.Mult Scler Relat Disord. 2017 May;14:72-79. doi: 10.1016/j.msard.2017.04.003. Epub 2017 Apr 9. Mult Scler Relat Disord. 2017. PMID: 28619436 Review.
-
Differential imaging of atypical demyelinating lesions of the central nervous system.Radiol Med. 2021 Jun;126(6):827-842. doi: 10.1007/s11547-021-01334-y. Epub 2021 Jan 24. Radiol Med. 2021. PMID: 33486703 Review.
-
Solitary Tumefactive Demyelinating Lesions in Children: Clinical and Magnetic Resonance Imaging Features, Pathologic Characteristics, and Outcomes.Pediatr Neurol. 2024 Aug;157:141-150. doi: 10.1016/j.pediatrneurol.2024.05.012. Epub 2024 May 20. Pediatr Neurol. 2024. PMID: 38917518
-
Utility of proton MR spectroscopy for differentiating typical and atypical primary central nervous system lymphomas from tumefactive demyelinating lesions.AJNR Am J Neuroradiol. 2014 Feb;35(2):270-7. doi: 10.3174/ajnr.A3677. Epub 2013 Aug 8. AJNR Am J Neuroradiol. 2014. PMID: 23928144 Free PMC article.
Cited by
-
Cerebrospinal Fluid Cytokine and Chemokine Profiles in Central Nervous System Sarcoidosis: Diagnostic and Immunopathologic Insights.Ann Neurol. 2024 Oct;96(4):704-714. doi: 10.1002/ana.27024. Epub 2024 Jul 19. Ann Neurol. 2024. PMID: 39031103
-
Cerebral vasculitis related to neurosarcoidosis: a case series and systematic literature review.J Neurol. 2025 Jan 15;272(2):135. doi: 10.1007/s00415-024-12868-2. J Neurol. 2025. PMID: 39812656 Free PMC article.
-
Reversibility of Tumor-like Lesions: Meticulous Diagnosis for Treatable Brain Diseases.Neurol Clin Pract. 2023 Oct;13(5):e200183. doi: 10.1212/CPJ.0000000000200183. Epub 2023 Aug 30. Neurol Clin Pract. 2023. PMID: 37664133 Free PMC article. No abstract available.
References
Publication types
LinkOut - more resources
Full Text Sources
Research Materials